Related Experiment Video

Updated: Apr 1, 2026

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.7K

Aflibercept (Eylea) and diabetic macular oedema. A first-choice VEGF inhibitor in case of marked visual loss

    Prescrire International
    |September 30, 2015
    PubMed

    Abstract:

    Overall, VEGF inhibitors administered by intravitreal injection have a similar harm-benefit balance. However, a publicly funded trial has shown that aflibercept is more effective than ranibizumab and bevacizumab in patients with marked loss of visual acuity.

    More Related Videos

    Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
    06:10

    Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

    Published on: March 30, 2020

    8.5K
    An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
    08:10

    An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

    Published on: January 25, 2019

    8.4K

    Related Experiment Videos

    Last Updated: Apr 1, 2026

    Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
    05:14

    Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

    Published on: August 11, 2023

    1.7K
    Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye06:10

    Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

    Published on: March 30, 2020

    8.5K
    An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy08:10

    An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

    Published on: January 25, 2019

    8.4K

    Related Concept Videos

    Open Angle Glaucoma: Treatment01:27

    Open Angle Glaucoma: Treatment

    1.1K
    In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
    Drugs such as carbonic anhydrase inhibitors, α2- and...
    1.1K
    Angle Closure Glaucoma: Treatment01:28

    Angle Closure Glaucoma: Treatment

    1.6K
    Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
    1.6K

    Articles linked to this work by shared authors, journal, and citation graph.

    Prescrire's Médicaments en Questions: First results of a practice improvement programme.

    Prescrire international·2019

    Resectable non-small cell lung cancer Adjuvant chemotherapy: slightly longer survival.

    Prescrire international·2019

    Diethylstilbestrol (DES): also harms the third generation.

    Prescrire international·2019

    Nivolumab (OPDIVOO) BRAF V600 mutation-negative metastatic or inoperable melanoma: survival advantage.

    Prescrire international·2019

    Trametinib (MEKINIST°) Metastatic or inoperable BRAF V600-positive melanoma: a few extra months of life.

    Prescrire international·2019

    Pharmaceutical research and development: a new system is needed.

    Prescrire international·2019
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us